Sabra Healthcare REIT Inc (SBRA)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $5.33B
Last updated: Nov 17, 2026 at 4:32 PM ET
Sabra Healthcare REIT Inc (SBRA) Stock Chart
Sabra Healthcare REIT (SBRA) has a latest price of $20.25 on Nov 17, 2026, 8.4% below its 52-week high of $22.10. Its price rose 13.6% over the past 12 months. The month-end price fell 15.3% over the 10 years through Oct 2026, a compound annual decline of 1.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $27.93 in Mar 2017 and its lowest $10.92 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SBRA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SBRA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price was flat, and over 6 months it fell 2.2%. The month-end price rose 44.7% over the 3 years through Oct 2026, a compound annual rate of 13.1%.
| Period | Change |
|---|---|
| 1 month | +7.7% |
| 3 months | 0.0% |
| 6 months | -2.2% |
| 12 months | +13.6% |
| 12 months, with dividends | +20.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +44.7% | +13.1% |
| 5 years | +39.5% | +6.9% |
| 10 years | -15.3% | -1.6% |
Price by Year
Its best calendar year was 2019, when the price rose 29.5%, and its weakest was 2017, when it fell 23.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.74 | +4.2% |
| 2025 | $18.94 | +9.4% |
| 2024 | $17.32 | +21.4% |
| 2023 | $14.27 | +14.8% |
| 2022 | $12.43 | -8.2% |
| 2021 | $13.54 | -22.0% |
| 2020 | $17.37 | -18.6% |
| 2019 | $21.34 | +29.5% |
| 2018 | $16.48 | -12.2% |
| 2017 | $18.77 | -23.1% |
Trading Range
The price is 3.3% above its 50-day average of $19.60 and 2.9% above its 200-day average of $19.68.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $20.25 | |
| 52-week high | $22.10 | -8.4% |
| 52-week low | $16.79 | +20.6% |
| 50-day average | $19.60 | +3.3% |
| 200-day average | $19.68 | +2.9% |
Price Risk
Over 3 years, its largest fall from a peak was 16.8%.
| Measure | Value |
|---|---|
| 1-year beta | -0.12 |
| Largest fall, 1 year | -16.1% |
| Largest fall, 3 years | -16.8% |
Valuation
Sabra Healthcare REIT is valued on funds from operations, at 12.1x its 2026 FFO estimate.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SBRA
What is SBRA's 1-year price change?
Sabra Healthcare REIT's price rose 13.6% over the past 12 months. With dividends included, the 12-month total return was 20.3%.
What is SBRA's 5-year price change?
Sabra Healthcare REIT's month-end price rose 39.5% over the 5 years through Oct 2026, a compound annual rate of 6.9%. These figures leave out dividends.
What is SBRA's 52-week high and low?
Sabra Healthcare REIT's 52-week high is $22.10 and its 52-week low is $16.79. Its latest price of $20.25 on Nov 17, 2026 is 8.4% below the high.
What is SBRA's beta?
Sabra Healthcare REIT's 1-year beta against the S&P 500 is -0.12, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 16.1%.
Is the SBRA chart free?
Yes. Advanced Charting for SBRA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SBRA pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors